arsenic trioxide has been researched along with Adverse Drug Event in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhattacharyya, P; Gehani, A; Ghara, N; Ghosh, P; Sarkar, S | 1 |
| Montesinos, P; Sanz, MA | 1 |
| Coombs, CC; Tallman, MS; Tavakkoli, M | 1 |
| Barnes, G; Kruse, M; Lo-Coco, F; Martin, M; Mueller, U; Pathak, A; Wildner, R | 1 |
| Cicconi, L; Lo-Coco, F | 1 |
| Chen, L; Chen, Q; Chen, S; Chen, Y; Chen, Z; Hu, J; Li, J; Li, X; Mi, J; Shen, Z; Sun, H; Wang, A; Wang, L; Wang, Z; Zhang, Y; Zhao, H; Zhao, W; Zhao, X; Zhou, W; Zhu, H | 1 |
| Au, WY; Kumana, CR; Kwong, YL; Lau, CP; Siu, CW; Tse, HF; Yung, C | 1 |
| Fan, SJ; Han, XY; Hu, LH; Wang, Y; Wu, N; Zhou, J | 1 |
| Au, WY; Kwong, YL | 1 |
| Ding, D; Fang, H; Kelly, R; Liu, Z; Shi, Q; Tong, W | 1 |
4 review(s) available for arsenic trioxide and Adverse Drug Event
| Article | Year |
|---|---|
How we prevent and treat differentiation syndrome in patients with acute promyelocytic leukemia.
Topics: Adult; Arsenic Trioxide; Arsenicals; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Leukemia, Promyelocytic, Acute; Male; Oxides; Premedication; Syndrome; Tretinoin | 2014 |
Acute promyelocytic leukemia: where did we start, where are we now, and the future.
Topics: Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Drug-Related Side Effects and Adverse Reactions; Humans; Leukemia, Promyelocytic, Acute; Oxides; Treatment Failure; Tretinoin | 2015 |
Current management of newly diagnosed acute promyelocytic leukemia.
Topics: Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Drug-Related Side Effects and Adverse Reactions; Humans; Leukemia, Promyelocytic, Acute; Oxides; Randomized Controlled Trials as Topic; Tretinoin | 2016 |
Arsenic trioxide: safety issues and their management.
Topics: Administration, Oral; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Humans; Lethal Dose 50; Oxides; Prodrugs | 2008 |
1 trial(s) available for arsenic trioxide and Adverse Drug Event
| Article | Year |
|---|---|
Effects of oral arsenic trioxide therapy on QT intervals in patients with acute promyelocytic leukemia: implications for long-term cardiac safety.
Topics: Administration, Oral; Adult; Aged; Arsenic Trioxide; Arsenicals; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Electrocardiography; Electrocardiography, Ambulatory; Female; Heart Conduction System; Heart Rate; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Oxides; Treatment Outcome | 2006 |
5 other study(ies) available for arsenic trioxide and Adverse Drug Event
| Article | Year |
|---|---|
Multidisciplinary corroboration in differentiation syndrome: a case report.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Leukemia, Promyelocytic, Acute; Syndrome; Tretinoin | 2021 |
Budgetary impact of treating acute promyelocytic leukemia patients with first-line arsenic trioxide and retinoic acid from an Italian payer perspective.
Topics: Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Italy; Leukemia, Promyelocytic, Acute; Male; Oxides; Tretinoin | 2015 |
The 12-year follow-up of survival, chronic adverse effects, and retention of arsenic in patients with acute promyelocytic leukemia.
Topics: Antineoplastic Agents; Arsenic; Arsenic Trioxide; Arsenicals; Case-Control Studies; Drug-Related Side Effects and Adverse Reactions; Female; Follow-Up Studies; Humans; Leukemia, Promyelocytic, Acute; Male; Oxides; Quality of Life; Survival Analysis | 2016 |
[Adverse effects of intravenous arsenic trioxide and their prevention].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Child; Child, Preschool; Drug-Related Side Effects and Adverse Reactions; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Oxides | 2006 |
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Models, Biological; Predictive Value of Tests | 2011 |